Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Prairie Pharms

Prairie Pharms
Angel LATEST DEAL TYPE (Cancelled)

Developer of small molecule plant extracts that contains Thymoquinone. The company's product used to create pharmaceutical grade, lipid soluble and cell permeable human health products.

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Commercial Products
Primary Office
  • 3261 Cameo Avenue
  • Nora Springs, IA 50458
  • United States

+1 (641) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Prairie Pharms’s full profile, request a free trial.

Prairie Pharms Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 14-Apr-2016 Cancelled Generating Revenue
1. Angel (individual) 29-May-2013 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Prairie Pharms Executive Team (2)

Name Title Board
William Rohlfsen Manager & Board Member

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »

Prairie Pharms Board Members (4)

Name Representing Role Since Contact
John Relher Prairie Pharms Board Member 000 0000
Joseph Saluri Prairie Pharms Board Member 000 0000
Nicholas Rohlfsen Prairie Pharms Board Member 000 0000
William Rohlfsen Prairie Pharms Manager & Board Member 000 0000